Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 22495078)

1.

Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy.

Schlagenhauf P, Blumentals WA, Suter P, Regep L, Vital-Durand G, Schaerer MT, Boutros MS, Rhein HG, Adamcova M.

Clin Infect Dis. 2012 Jun;54(11):e124-31. doi: 10.1093/cid/cis215. Epub 2012 Apr 10.

2.

Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure.

Nevin RL.

Clin Infect Dis. 2012 Oct;55(8):1167-8; author reply 1168-9. Epub 2012 Jul 3. No abstract available.

3.

Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.

Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere B, Schildknecht J, Fuchs E, Edwards R.

J Travel Med. 1998 Sep;5(3):121-6.

PMID:
9772329
4.

Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy.

Vanhauwere B, Maradit H, Kerr L.

Am J Trop Med Hyg. 1998 Jan;58(1):17-21.

5.

Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.

Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M.

J Infect Dis. 2009 Sep 15;200(6):991-1001. doi: 10.1086/605474.

6.

Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.

Denoeud-Ndam L, Clément MC, Briand V, Akakpo J, Agossou VK, Atadokpédé F, Dossou-Gbété L, Komongui DG, Afangnihoun A, Girard PM, Zannou DM, Cot M.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):64-72.

PMID:
22706291
7.

Mefloquine safety and tolerability in pregnancy: a systematic literature review.

González R, Hellgren U, Greenwood B, Menéndez C.

Malar J. 2014 Feb 28;13:75. doi: 10.1186/1475-2875-13-75. Review.

8.

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

Denoeud-Ndam L, Zannou DM, Fourcade C, Taron-Brocard C, Porcher R, Atadokpede F, Komongui DG, Dossou-Gbete L, Afangnihoun A, Ndam NT, Girard PM, Cot M.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):198-206. doi: 10.1097/QAI.0000000000000058.

PMID:
24220287
9.

The effects of mefloquine treatment in pregnancy.

Nosten F, Vincenti M, Simpson J, Yei P, Thwai KL, de Vries A, Chongsuphajaisiddhi T, White NJ.

Clin Infect Dis. 1999 Apr;28(4):808-15.

10.

Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.

Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):50-6.

PMID:
8702037
11.

Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.

Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):24-32.

PMID:
8702034
12.

The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen.

Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL.

J Infect Dis. 1997 Sep;176(3):831-3.

13.

Pregnancy and mefloquine prevention of malaria.

[No authors listed]

Prescrire Int. 2000 Dec;9(50):180-1.

PMID:
11475498
14.

Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.

Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J.

Drug Saf. 2007;30(3):247-64. Review.

PMID:
17343431
15.

The position of mefloquine as a 21st century malaria chemoprophylaxis.

Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG.

Malar J. 2010 Dec 9;9:357. doi: 10.1186/1475-2875-9-357. Review.

17.

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM.

Malar J. 2010 Sep 1;9:249. doi: 10.1186/1475-2875-9-249.

18.

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O, Kennedy D, Voyer Lavigne S, De Santis M, Einarson A.

J Clin Psychiatry. 2006 Aug;67(8):1280-4.

PMID:
16965209
19.

Epidemiology of isotretinoin exposure during pregnancy.

Dai WS, LaBraico JM, Stern RS.

J Am Acad Dermatol. 1992 Apr;26(4):599-606.

PMID:
1597546
20.

Mefloquine gap junction blockade and risk of pregnancy loss.

Nevin RL.

Biol Reprod. 2012 Sep 21;87(3):65. Print 2012 Sep. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk